Parus Finance (UK)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-26,328
| Closed | -$3.13M | – | 36 |
|
|
2024
Q2 | $3.13M | Buy |
26,328
+444
| +2% | +$52.7K | 0.9% | 21 |
|
|
2024
Q1 | $2.76M | Sell |
25,884
-1,194
| -4% | -$127K | 1.04% | 20 |
|
|
2023
Q4 | $2.69M | Sell |
27,078
-316
| -1% | -$31.4K | 1.4% | 17 |
|
|
2023
Q3 | $2.83M | Sell |
27,394
-3,404
| -11% | -$352K | 1.76% | 17 |
|
|
2023
Q2 | $3.74M | Sell |
30,798
-1,381
| -4% | -$168K | 1.55% | 15 |
|
|
2023
Q1 | $4.94M | Buy |
32,179
+572
| +2% | +$87.8K | 2.96% | 11 |
|
|
2022
Q4 | $5.68M | Buy |
31,607
+4,740
| +18% | +$851K | 3.86% | 11 |
|
|
2022
Q3 | $3.18M | Sell |
26,867
-12,510
| -32% | -$1.48M | 2.76% | 12 |
|
|
2022
Q2 | $5.63M | Buy |
39,377
+30,010
| +320% | +$4.29M | 3.35% | 15 |
|
|
2022
Q1 | $1.61M | Sell |
9,367
-3,296
| -26% | -$568K | 0.58% | 26 |
|
|
2021
Q4 | $3.22M | Sell |
12,663
-15,244
| -55% | -$3.87M | 1.03% | 23 |
|
|
2021
Q3 | $10.7M | Sell |
27,907
-49,163
| -64% | -$18.9M | 3.1% | 11 |
|
|
2021
Q2 | $18.1M | Buy |
77,070
+7,201
| +10% | +$1.69M | 4.39% | 7 |
|
|
2021
Q1 | $9.15M | Buy |
69,869
+19,859
| +40% | +$2.6M | 2.51% | 15 |
|
|
2020
Q4 | $5.23M | Buy |
+50,010
| New | +$5.23M | 1.53% | 22 |
|